David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$686M |
| 2 |
Walt Disney
DIS
|
+$555M |
| 3 |
Palantir
PLTR
|
+$522M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$493M |
| 5 |
TSMC
TSM
|
+$464M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$981M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 4 |
Eli Lilly
LLY
|
+$555M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.18% |
| 2 | Healthcare | 9.91% |
| 3 | Consumer Discretionary | 9.25% |
| 4 | Financials | 6.45% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Rambus
RMBS
$9.76B
| $2.94M | ﹤0.01% |
56,758
-337,594
| -86% | -$19.8M |
|
2202
PUT
NuScale Power
SMR
$3.8B
| $2.93M | ﹤0.01% |
206,900
+184,900
| +840% | +$3.74M |
|
2203
CALL
Cytokinetics
CYTK
$11B
| $2.92M | ﹤0.01% |
72,700
-11,600
| -14% | -$533K |
|
2204
Koppers
KOP
$876M
| $2.91M | ﹤0.01% |
104,092
+41,737
| +67% | +$1.26M |
|
|
AEVA
2205
Aeva Technologies
AEVA
$1.1B
| $2.91M | ﹤0.01% |
416,300
+154,515
| +59% | +$637K |
|
2206
GXO Logistics
GXO
$5.5B
| $2.91M | ﹤0.01% |
74,559
+1,279
| +2% | +$53.4K |
|
2207
PUT
Boston Properties
BXP
$11.2B
| $2.9M | ﹤0.01% |
43,200
+34,800
| +414% | +$2.44M |
|
2208
PUT
Axcelis
ACLS
$3.72B
| $2.9M | ﹤0.01% |
58,400
-20,000
| -26% | -$1.26M |
|
|
AAMI
2209
Acadian Asset Management
AAMI
$3.39B
| $2.9M | ﹤0.01% |
112,157
+33,345
| +42% | +$838K |
|
2210
CALL
IMAX
IMAX
$2.89B
| $2.9M | ﹤0.01% |
+110,000
| New | +$2.74M |
|
2211
PUT
Astera Labs
ALAB
$50.4B
| $2.89M | ﹤0.01% |
48,500
+3,500
| +8% | +$324K |
|
2212
OGE Energy
OGE
$9.62B
| $2.89M | ﹤0.01% |
62,961
+56,436
| +865% | +$2.46M |
|
2213
BridgeBio Pharma
BBIO
$15.5B
| $2.87M | ﹤0.01% |
+83,149
| New | +$2.8M |
|
2214
Futu Holdings
FUTU
$17.9B
| $2.86M | ﹤0.01% |
27,945
-6,226
| -18% | -$637K |
|
2215
PUT
Pultegroup
PHM
$24.8B
| $2.85M | ﹤0.01% |
27,700
-42,300
| -60% | -$4.57M |
|
2216
Acco Brands
ACCO
$387M
| $2.84M | ﹤0.01% |
678,379
+374,520
| +123% | +$1.84M |
|
|
VPU
2217
Vanguard Utilities ETF
VPU
$8.4B
| $2.84M | ﹤0.01% |
16,618
-13,015
| -44% | -$2.2M |
|
|
BBT
2218
Beacon Financial Corp
BBT
$2.66B
| $2.84M | ﹤0.01% |
108,760
+83,520
| +331% | +$2.33M |
|
2219
Liberty Media Series A
FWONA
$23.9B
| $2.84M | ﹤0.01% |
34,829
-3,375
| -9% | -$287K |
|
2220
Virtus Investment Partners
VRTS
$1.12B
| $2.84M | ﹤0.01% |
16,453
+8,651
| +111% | +$1.65M |
|
2221
WD-40
WDFC
$2.91B
| $2.84M | ﹤0.01% |
11,620
-14,348
| -55% | -$3.39M |
|
2222
Cannae Holdings
CNNE
$671M
| $2.83M | ﹤0.01% |
154,407
+137,433
| +810% | +$2.59M |
|
|
MRC
2223
DELISTED
MRC Global
MRC
| $2.83M | ﹤0.01% |
246,526
-105,432
| -30% | -$1.36M |
|
2224
Douglas Elliman
DOUG
$171M
| $2.83M | ﹤0.01% |
1,643,357
-482,277
| -23% | -$873K |
|
2225
PUT
Archer Daniels Midland
ADM
$38.6B
| $2.82M | ﹤0.01% |
58,800
-289,800
| -83% | -$14M |
|
Similar funds
David Shaw's Q1 2025 Portfolio in Review
As of Q1 2025, David Shaw held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $6.08B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.
- David Shaw's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
- David Shaw added most to GE Vernova in Q1 2025, an estimated $686M increase.
- David Shaw's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
- David Shaw's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
- David Shaw opened 569 new positions and closed 704 in Q1 2025.
- David Shaw's portfolio value fell 18% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.